InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026)

InfuSystem Holdings (INFU) posted Cash from Investing Activities of -$1.3 million for Q1 2026, up 42.52% on a QoQ basis from -$2.2 million in Q4 2025, and up 52.65% year-over-year from -$825421.0 in Q1 2025.

InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026) Analysis & Trends

InfuSystem Holdings' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 52.65% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (up 65.19% YoY) and the FY2025 annual result came in at -$6.8 million, up 48.71% from the prior year.
  • Cash from Investing Activities was -$1.3 million for Q1 2026 at InfuSystem Holdings, up from -$2.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$252000.0 in Q3 2025 and bottomed at -$6.7 million in Q2 2024.
  • A 5-year average of -$2.3 million and a median of -$2.3 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 91.43% — and 2024, when it sank 852.0%.
  • InfuSystem Holdings' Cash from Investing Activities stood at -$3.1 million in 2022, then jumped by 65.79% to -$1.0 million in 2023, then sank by 213.12% to -$3.3 million in 2024, then jumped by 32.95% to -$2.2 million in 2025, then soared by 42.52% to -$1.3 million in 2026.
  • Business Quant data shows INFU's Cash from Investing Activities at -$1.3 million in Q1 2026, -$2.2 million in Q4 2025, and -$252000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 InfuSystem Holdings 188.97 Mn 186.87 Mn 19.68 Mn -1.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.26 Mn
Mar 31, 2026 -1.26 Mn
Dec 31, 2025 -2.19 Mn
Dec 31, 2025 -2.19 Mn
Sep 30, 2025 -252,000.00
Sep 30, 2025 -252,000.00
Jun 30, 2025 -1.69 Mn
Jun 30, 2025 -1.69 Mn
Mar 31, 2025 -2.66 Mn
Mar 31, 2025 -2.66 Mn
Dec 31, 2024 -3.27 Mn
Dec 31, 2024 -3.27 Mn
Sep 30, 2024 -2.86 Mn
Sep 30, 2024 -2.86 Mn
Jun 30, 2024 -6.70 Mn
Jun 30, 2024 -6.70 Mn
Mar 31, 2024 -418,000.00
Mar 31, 2024 -418,000.00
Dec 31, 2023 -1.04 Mn
Dec 31, 2023 -1.04 Mn